Vibativ Approval History

Vibativ (telavancin) is a bactericidal, once-daily injectable antibiotic for the treatment of complicated skin and skin structure infections (cSSSI), and hospital-acquired and ventilator-associated bacterial pneumonia.

FDA Approval History for Vibativ

DateArticle
Jun 21, 2013Approval FDA Approves Vibativ for Hospitalized Patients with Bacterial Pneumonia
Sep 13, 2009Approval Theravance and Astellas Announce FDA Approval of Vibativ (telavancin) for the Treatment of Complicated Skin and Skin Structure Infections
Apr 25, 2009FDA Accepts for Review Theravance's Complete Response Submission for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Apr  7, 2009Theravance Announces FDA Acceptance of Telavancin NDA for the Treatment of Hospital-Acquired Pneumonia
Feb 27, 2009Theravance Receives Complete Response Letter on the Telavancin New Drug Application for the Treatment of cSSSI
Jan 27, 2009Theravance Submits U.S. NDA for Telavancin for the Treatment of Hospital-Acquired Pneumonia
Nov 20, 2008Theravance Reports Favorable Outcome of FDA Advisory Committee Meeting on Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Mar  6, 2008FDA Accepts for Review Theravance's Complete Response to Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections
Jan  2, 2008Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web4)